News Sentiment

COCH sentiment intelligence

Envoy Medical Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 56 Balanced news tone 49 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 0.70 Week of 17 Jul 2026
Weighted tone 56/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

77/100 classification confidence.

Company focus 49

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

+2.7% over one week, +10.7% over four weeks, trend active, and below fair value.

Latest direct headline Neutral

Abbott stock trades steady as diagnostics and medical devices underpin earnings momentum

Market Reaction

Balanced read

64/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 77/100 classification
One-week reaction 2.7% Price confirming higher
Trend fit Trend active 10.7% over four weeks
Fair value -69.8% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 16
Neutral 28
Negative 5

Relevance

Why the article matched

Direct first
Direct company coverage 49
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 17
TMX Newsfile 8
Stock Titan 7
Investing.com 3
Ad-hoc-news.de 2
TradingView 2
Benzinga 1
Sahm 1

Event Lens

What the news is about

Classified themes
Market update 23
Earnings 18
Regulatory and legal 7
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-49 of 49
Stock Titan Direct company coverage

Envoy Medical (NASDAQ: COCH) granted more time to meet Nasdaq $1 bid rule

Envoy Medical (NASDAQ: COCH) has received an additional 180-day extension from Nasdaq, until November 16, 2026, to regain compliance with the $1.00 minimum bid price requirement. The company's Class A common stock had previously traded below $1.00 for 30 consecutive business days

Tone
Negative 40/100
Event
Market update
Published
22 May 2026 20:10
Source
Stock Titan
TMX Newsfile Direct company coverage

Envoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology

Envoy Medical Inc. (NASDAQ: COCH) has significantly expanded its intellectual property portfolio with the issuance of multiple patents in Australia and Europe, alongside an upcoming European patent grant. These patents focus on fully implanted hearing technology, covering innovat

Tone
Positive 75/100
Event
Market update
Published
21 May 2026 11:08
Source
TMX Newsfile
Investing.com Direct company coverage

Envoy Medical shareholders approve plan amendments and board elections at annual meeting

Envoy Medical shareholders approved amendments to the company's 2023 Equity Incentive Plan and 2023 Employee Stock Purchase Plan, authorizing additional shares. They also elected Brent T. Lucas and Susan J. Kantor to the board, ratified EisnerAmper, LLP as the independent account

Tone
Positive 66/100
Event
Market update
Published
18 May 2026 20:40
Source
Investing.com
Stock Titan Direct company coverage

Envoy Medical (NASDAQ: COCH) holders back larger equity and stock purchase plans

Envoy Medical, Inc. (NASDAQ: COCH) stockholders approved significant amendments to the company's 2023 Equity Incentive Plan and 2023 Employee Stock Purchase Plan at their 2026 Annual Meeting. These amendments authorize an additional 6,000,000 shares for equity awards and 1,200,00

Tone
Positive 66/100
Event
Market update
Published
18 May 2026 19:40
Source
Stock Titan